Krystal Biotech Inc.
KRYS | NASDAQ
$333.85
-$2.82 (-0.84%)
At close: Sep 21, 2026, 4:00 PM ET
$333.85
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 440.48M | 417.3M | 389.13M | 373.16M | 359.21M | 333.45M | 290.51M | 241.52M | 166.23M | 95.95M | 50.7M | 8.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 29.34M | 30.07M | 28.77M | 22.81M | 23.83M | 22.67M | 20.06M | 19.49M | 13.03M | 7.02M | 4.6M | 223K | n/a | n/a | 1.01M | 1.01M | 1.01M | 1.01M | n/a | n/a | n/a | n/a |
Gross Profit | 411.14M | 387.24M | 360.36M | 350.36M | 335.38M | 310.78M | 270.45M | 222.03M | 153.2M | 88.93M | 46.1M | 8.33M | n/a | n/a | -1.01M | -1.01M | -1.01M | -1.01M | n/a | n/a | n/a | n/a |
Operating Income | 197.92M | 178.81M | 161.3M | 158.24M | 139.3M | 108.56M | 65.69M | 27.45M | -20.97M | -67.59M | -109.73M | -147.64M | -153.09M | -143.8M | -120.2M | -107.3M | -91.5M | -79.14M | -68.27M | -56.82M | -50.85M | -41.41M |
Interest Income | 7.95M | 7.75M | 7.42M | 28.71M | 29.42M | 29.43M | 29.62M | 29.91M | 29.35M | 26.71M | 22.62M | 17.82M | 12.68M | 8.49M | 5.22M | 2.57M | 1.04M | 420K | 196K | 163K | 170K | 261K |
Pretax Income | 226.62M | 207.32M | 189.47M | 186.95M | 168.75M | 138.02M | 95.36M | 57.4M | 108.38M | 59.13M | 12.9M | -29.81M | -140.41M | -135.31M | -139.98M | -129.73M | -115.47M | -103.72M | -69.57M | -58.15M | -52.17M | -42.64M |
Net Income | 241.47M | 225.03M | 204.83M | 198.91M | 146.73M | 123.96M | 89.16M | 52.37M | 105.94M | 57.16M | 10.93M | -29.81M | -140.41M | -135.31M | -139.98M | -129.73M | -115.47M | -103.72M | -69.57M | -58.15M | -52.17M | -42.64M |
Selling & General & Admin | 159.72M | 155.03M | 146.74M | 136.75M | 127.88M | 120.35M | 113.69M | 105.65M | 100.64M | 98.92M | 96.89M | 97.67M | 93.9M | 85.86M | 77.18M | 66.02M | 55.66M | 47.59M | 40.39M | 32.27M | 27.28M | 20.8M |
Research & Development | 59.23M | 59.12M | 58.05M | 55.37M | 55.7M | 56.87M | 53.57M | 51.42M | 48.54M | 45.1M | 46.43M | 45.8M | 46.69M | 45.44M | 42M | 40.27M | 34.83M | 30.54M | 27.88M | 24.55M | 23.57M | 20.61M |
Other Expenses | -5.72M | -5.72M | -5.72M | n/a | 12.5M | 25M | 37.5M | 37.5M | 25M | 12.5M | 12.5M | 12.5M | 12.5M | 12.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 213.23M | 208.43M | 199.06M | 192.12M | 196.08M | 202.22M | 204.76M | 194.58M | 174.18M | 156.52M | 155.82M | 155.97M | 153.09M | 143.8M | 119.18M | 106.29M | 90.49M | 78.13M | 68.27M | 56.82M | 50.85M | 41.41M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.49M | 1.49M | 1.49M | 1.49M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -50.38M | -50.38M | -50.38M | -50.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 242.57M | 238.5M | 227.84M | 214.93M | 219.91M | 224.89M | 224.82M | 214.07M | 187.21M | 163.54M | 160.43M | 156.19M | 153.09M | 143.8M | 120.2M | 107.3M | 91.5M | 79.14M | 68.27M | 56.82M | 50.85M | 41.41M |
Income Tax Expense | -14.85M | -17.71M | -15.36M | -11.96M | 22.03M | 14.06M | 6.2M | 5.03M | 2.44M | 1.97M | 1.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 29.53M | 29.29M | 28.94M | 28.95M | 28.91M | 28.82M | 28.76M | 28.72M | 28.6M | 28.3M | 28.17M | 28.04M | 26.66M | 25.71M | 25.56M | 25.62M | 25.55M | 25.11M | 22.2M | 22.21M | 22.2M | 21.25M |
Shares Outstanding (Diluted) | 30.66M | 30.51M | 29.95M | 29.83M | 29.75M | 29.87M | 29.88M | 29.9M | 29.64M | 29.29M | 28.82M | 28.89M | 26.66M | 25.71M | 25.56M | 25.62M | 25.55M | 25.11M | 22.2M | 22.21M | 22.2M | 21.25M |
EPS (Basic) | 8.27 | 7.75 | 7.08 | 6.89 | 5.10 | 4.31 | 3.10 | 1.83 | 3.76 | 1.97 | 0.18 | -1.38 | -5.43 | -5.28 | -5.51 | -5.24 | -4.77 | -4.41 | -3.16 | -2.70 | -2.49 | -2.12 |
EPS (Diluted) | 7.98 | 7.48 | 6.85 | 6.67 | 4.92 | 4.16 | 2.99 | 1.77 | 3.65 | 1.87 | 0.08 | -1.47 | -5.43 | -5.28 | -5.51 | -5.24 | -4.77 | -4.41 | -3.16 | -2.70 | -2.49 | -2.12 |
EBITDA | 218.43M | 200.67M | 182.73M | 193.29M | 180.18M | 154.95M | 117.14M | 79.14M | 124.79M | 69.97M | 27.53M | -15.6M | -126.58M | -121.98M | -135.92M | -125.98M | -111.91M | -100.48M | -65.31M | -54.22M | -48.54M | -39.21M |
EBIT | 213.33M | 194.03M | 176.18M | 186.95M | 173.92M | 148.21M | 110.43M | 72.47M | 118.29M | 64.01M | 21.87M | -20.84M | -131.44M | -126.33M | -139.98M | -129.73M | -115.47M | -103.72M | -68.08M | -56.69M | -50.71M | -41.18M |
Depreciation & Amortization | 5.1M | 6.64M | 6.55M | 6.34M | 6.26M | 6.74M | 6.71M | 6.67M | 6.5M | 5.96M | 5.66M | 5.24M | 4.85M | 4.35M | 4.05M | 3.75M | 3.56M | 3.25M | 2.77M | 2.48M | 2.17M | 1.98M |
Add to Watchlist
Select watchlists to add or remove KRYS